Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Armin Scheffler

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
BMC Neurology|October 13, 2021
Reduced vestibular perception thresholds in persistent postural-perceptual dizziness- a cross-sectional studySebastian Wurthmann, Dagny Holle, Mark Obermann, et al.
Skin Pharmacology and Physiology|July 19, 2014
Accelerated reepithelialization by triterpenes: proof of concept in the healing of surgical skin lesionsHans-Robert Metelmann, Johanna M Brandner, Hauke Schumann, et al.
The Journal of Headache and Pain|July 4, 2024
Persistent effectiveness of CGRP antibody therapy in migraine and comorbid medication overuse or medication overuse headache - a retrospective real-world analysisArmin Scheffler, Jale Basten, Lennart Menzel, et al.
The Journal of Headache and Pain|May 16, 2024
Effectiveness and tolerability of eptinezumab in treating patients with migraine resistant to conventional preventive medications and CGRP (receptor) antibodies: a multicentre retrospective real-world analysis from GermanyArmin Scheffler, Pauline Wenzel, Merle Bendig, et al.
The Journal of Investigative Dermatology|August 14, 2009
Triterpenes promote keratinocyte differentiation in vitro, ex vivo and in vivo: a role for the transient receptor potential canonical (subtype) 6Ute Woelfle, Melanie N Laszczyk, Margarethe Kraus, et al.
Neurological Research and Practice|December 16, 2020
Prevention of migraine with monoclonal antibodies against CGRP or the CGRP receptor: Addition to the S1 guideline: Therapy of migraine attacks and prevention of migraine. Recommendations of the Germany Society of Neurology and the German Migraine and Headache SocietyHans-Christoph Diener, Stefanie Förderreuther, Charly Gaul, et al.
Frontiers in Neurology|January 3, 2022
Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in MenRaffaele Ornello, Carlo Baraldi, Simona Guerzoni, et al.
The Journal of Headache and Pain|March 20, 2022
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen studyRaffaele Ornello, Carlo Baraldi, Simona Guerzoni, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
BMC Neurology|October 13, 2021
Reduced vestibular perception thresholds in persistent postural-perceptual dizziness- a cross-sectional studySebastian Wurthmann, Dagny Holle, Mark Obermann, et al.
Skin Pharmacology and Physiology|July 19, 2014
Accelerated reepithelialization by triterpenes: proof of concept in the healing of surgical skin lesionsHans-Robert Metelmann, Johanna M Brandner, Hauke Schumann, et al.
The Journal of Headache and Pain|July 4, 2024
Persistent effectiveness of CGRP antibody therapy in migraine and comorbid medication overuse or medication overuse headache - a retrospective real-world analysisArmin Scheffler, Jale Basten, Lennart Menzel, et al.
The Journal of Headache and Pain|May 16, 2024
Effectiveness and tolerability of eptinezumab in treating patients with migraine resistant to conventional preventive medications and CGRP (receptor) antibodies: a multicentre retrospective real-world analysis from GermanyArmin Scheffler, Pauline Wenzel, Merle Bendig, et al.
The Journal of Investigative Dermatology|August 14, 2009
Triterpenes promote keratinocyte differentiation in vitro, ex vivo and in vivo: a role for the transient receptor potential canonical (subtype) 6Ute Woelfle, Melanie N Laszczyk, Margarethe Kraus, et al.
Neurological Research and Practice|December 16, 2020
Prevention of migraine with monoclonal antibodies against CGRP or the CGRP receptor: Addition to the S1 guideline: Therapy of migraine attacks and prevention of migraine. Recommendations of the Germany Society of Neurology and the German Migraine and Headache SocietyHans-Christoph Diener, Stefanie Förderreuther, Charly Gaul, et al.
Frontiers in Neurology|January 3, 2022
Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in MenRaffaele Ornello, Carlo Baraldi, Simona Guerzoni, et al.
The Journal of Headache and Pain|March 20, 2022
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen studyRaffaele Ornello, Carlo Baraldi, Simona Guerzoni, et al.
Pageof 3